3/20
08:09 am
qgen
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results [Yahoo! Finance]
Low
Report
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results [Yahoo! Finance]
3/20
07:30 am
qgen
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
Low
Report
Qiagen Announces Form 20-F Annual Report Filing for 2025 Results
3/19
04:39 pm
qgen
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention [Yahoo! Finance]
Medium
Report
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention [Yahoo! Finance]
3/19
04:05 pm
qgen
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
Low
Report
QIAGEN Highlights Newly Published Data Supporting Efficacy of QuantiFERON for TB Prevention
3/11
07:18 am
qgen
Qiagen (QGEN) was downgraded by Zacks Research from "hold" to "strong sell".
Medium
Report
Qiagen (QGEN) was downgraded by Zacks Research from "hold" to "strong sell".
3/10
05:25 pm
qgen
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System [Yahoo! Finance]
Medium
Report
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System [Yahoo! Finance]
3/10
05:05 pm
qgen
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
Medium
Report
QIAGEN Receives U.S. Clearance for Gastrointestinal Panels on Fully Automated QIAstat-Dx Rise Syndromic Testing System
2/26
07:10 am
qgen
Immunoassay for Neurological Biomarkers Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 [Yahoo! Finance]
Low
Report
Immunoassay for Neurological Biomarkers Market Research 2026 - Global Industry Size, Share, Trends, Opportunity, & Forecast, 2020-2030 [Yahoo! Finance]
2/19
08:00 am
qgen
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
Low
Report
Parse Biosciences Launches Evercode Whole Transcriptome V4 With Shorter Workflow, Higher Sensitivity and Higher Cell Recovery
2/9
10:06 am
qgen
Qiagen (NYSE:QGEN) was given a new $52.00 price target on by analysts at UBS Group AG.
Low
Report
Qiagen (NYSE:QGEN) was given a new $52.00 price target on by analysts at UBS Group AG.
2/6
03:59 pm
qgen
Qiagen (NYSE:QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $60.00. They now have an "overweight" rating on the stock.
Low
Report
Qiagen (NYSE:QGEN) had its price target raised by analysts at JPMorgan Chase & Co. from $55.00 to $60.00. They now have an "overweight" rating on the stock.
2/6
02:49 pm
qgen
Qiagen (NYSE:QGEN) had its price target lowered by analysts at Citigroup Inc. from $55.40 to $55.00. They now have a "neutral" rating on the stock.
Low
Report
Qiagen (NYSE:QGEN) had its price target lowered by analysts at Citigroup Inc. from $55.40 to $55.00. They now have a "neutral" rating on the stock.
2/6
12:00 pm
qgen
Qiagen (NYSE:QGEN) was given a new $53.00 price target on by analysts at Robert W. Baird.
Low
Report
Qiagen (NYSE:QGEN) was given a new $53.00 price target on by analysts at Robert W. Baird.
2/6
10:58 am
qgen
Qiagen (NYSE:QGEN) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
Low
Report
Qiagen (NYSE:QGEN) was given a new $50.00 price target on by analysts at Stifel Nicolaus.
2/6
10:08 am
qgen
Qiagen (NYSE:QGEN) had its "hold" rating reaffirmed by analysts at TD Cowen.
Low
Report
Qiagen (NYSE:QGEN) had its "hold" rating reaffirmed by analysts at TD Cowen.
2/6
07:07 am
qgen
Qiagen (NYSE:QGEN) was given a new $58.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
Low
Report
Qiagen (NYSE:QGEN) was given a new $58.00 price target on by analysts at Barclays PLC. They now have an "overweight" rating on the stock.
2/5
04:16 pm
qgen
Qiagen (NYSE:QGEN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
Low
Report
Qiagen (NYSE:QGEN) had its "buy" rating reaffirmed by analysts at Jefferies Financial Group Inc..
2/4
04:27 pm
qgen
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars [Yahoo! Finance]
Low
Report
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars [Yahoo! Finance]
2/4
04:05 pm
qgen
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
Low
Report
QIAGEN Exceeds Q4 2025 Outlook Driven by Growth Pillars
2/3
04:05 pm
qgen
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
Low
Report
QIAGEN Showcases QIAsprint Connect High-Throughput Automation System for Labs Worldwide at SLAS 2026
1/28
12:26 pm
qgen
Activist Fivespan Partners takes 6% stake in Appian [Yahoo! Finance]
Low
Report
Activist Fivespan Partners takes 6% stake in Appian [Yahoo! Finance]
1/26
04:46 pm
qgen
QIAGEN Appoints Mark Stevenson to Supervisory Board [Yahoo! Finance]
Low
Report
QIAGEN Appoints Mark Stevenson to Supervisory Board [Yahoo! Finance]
1/26
04:05 pm
qgen
QIAGEN Appoints Mark Stevenson to Supervisory Board
Neutral
Report
QIAGEN Appoints Mark Stevenson to Supervisory Board
1/22
06:01 am
qgen
Qiagen (NYSE:QGEN) was downgraded by analysts at Deutsche Bank Aktiengesellschaft to a "hold" rating.
Low
Report
Qiagen (NYSE:QGEN) was downgraded by analysts at Deutsche Bank Aktiengesellschaft to a "hold" rating.
1/21
02:03 pm
qgen
Qiagen (NYSE:QGEN) had its "neutral" rating reaffirmed by analysts at UBS Group AG.
Low
Report
Qiagen (NYSE:QGEN) had its "neutral" rating reaffirmed by analysts at UBS Group AG.